In the field of prostate cancer, one of the key goals of researchers and physicians is to reduce the morbidity and mortality associated with the condition. Strategies to help achieve this goal include screening, surgery, therapy (pharmacological, chemotherapy, and radiotherapy), and prevention.
Malpractice Consult: What to know about direct examination of expert witnesses
December 4th 2023"In the 21st century, expert witnesses serve a vital role in presenting evidence to a jury. A good expert will be able to distill complex information into digestible elements the jurors can understand," writes Austin Richards, Esq.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.